SAHAKYAN, Y.; ERMAN, A. .; BHOJANI, N. .; CHUGHTAI, B. .; ZORN, K. C.; SANDER, B.; ELTERMAN, D. S. Cost-utility of minimally invasive therapies vs. pharmacotherapy as initial therapy for benign prostatic hyperplasia: A Canadian healthcare payer perspective. Canadian Urological Association Journal, [S. l.], v. 17, n. 4, p. 103–10, 2022. DOI: 10.5489/cuaj.8045. Disponível em: https://cuaj.ca/index.php/journal/article/view/8045. Acesso em: 29 mar. 2024.